Dr. Frydenberg discusses MRI’s potential as a screening tool

Article

Mark Frydenberg, MD, of Australia's Monash University, discusses whether multiparametric MRI is ready to be used as a screening modality for prostate cancer.

Is multiparametric MRI at a point where urologists could use it as a screening modality for prostate cancer? In this interview, Mark Frydenberg, MD, of Monash University in Melbourne, Victoria, Australia, addresses this question and how the use of MRI is changing.

Also see - PET use in prostate cancer widens, but questions remain: An interview with Mark Frydenberg, MD

Related Videos
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
Brian T. Helfand, MD, and Matthew Smith, MD, PhD, experts on prostate cancer
blur image background of corridor in hospital or clinic image | Image Credit: © whyframeshot - stock.adobe.com
Jill M. Hamilton Reeves, PhD, RD, CSO, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.